Friday, 17 Aug 2018

You are here

Shoe Inserts Disappoint with Plantar Heel Pain

A report from the British Journal of Sports Medicine shows that commonly used drug store shoe inserts or customized orthotics are often ineffective in managing plantar heel pain. (Citation source bit.ly/2puzUbm)

Reuters reports on the results of a study addressing plantar heel pain that accounts for as much as 15% of foot symptoms  and 10% of running injuries. 

A systematic review of the literature included 20 randomized controlled trials comparing foot orthoses with a control population (either no intervention, sham or other conservative treatment) in patients with plantar heel pain (PHP).

Six studies showed no difference in short-term outcomes between prefabricated orthoses and sham orthoses for pain.

No difference was found between prefabricated orthoses and custom orthoses for pain at short term.

Results suggests that orthotics might work for some people, but not others, and that time, rather than the insert, may be most important in the ultimate outcomes.

Other options for patients with PHP includes the use of night splints, stretching exercises, supervised physical therapy or modification of exercise and lifestyle.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Managing Comorbidity and Poor Drug Responses

Comorbidity is pervasive and complicates medical care in general. It can be a by-product of aging. It may result from drug therapy or an inciting disease process and may be part of the constellation that defines the primary disorder. A growing body of evidence that suggests that comorbidity has a significant dampening effect on drug responsiveness and, adds to poorer outcomes in patients with inflammatory arthritis.

Opioid Aversion is Augmenting Spinal Steroid Injections

As physicians turn away from opioids, are they resorting to options that may also be unsafe?

The New York Times reports that some physicians are using the anti-inflammatory drug, Depo-Medrol, for intraspinal injections to manage painful spinal and perispinal disorders.

Company Payments to Rheumatologists, Specialists Linked to Increased ACTH Prescriptions

Despite its exorbitant price tag and paucity of supportive clinical evidence, ACTH (corticotropin) sales have increased in the United States. A recent JAMA article examined its use by specialists and found that those who prescribe ACTH (including rheumatologists, nephrologists, neurologists) received corticotropin-related payments from the products sole manufacturer, Mallinckrod.

Veterans Administration Shuns Marijuana as an Option

Cannabis therapy is legal in 30 states in the US, and soon to be legal in Canada and Great Britian, but the US Veterans Administration continues to reject medical marijuana as a therapeutic option - even in states where it is approved.

Predictors of Methotrexate Non-Response

New research from a UK study suggests that nonresponse to oral or subcutaneous MTX was seen in 43% and is predicted by seronegativity, higher disease activity measures and higher anxiety scores.